1. Home
  2. CSTL

CSTL

Castle Biosciences Inc.

Logo Castle Biosciences Inc.

Health Care

Medical Specialities

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Founded: 2007 Country:
United States
United States
Employees: N/A City: FRIENDSWOOD
Market Cap: 571.5M IPO Year: 2019
Target Price: $32.11 AVG Volume (30 days): 237.8K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.14 EPS Growth: N/A
52 Week Low/High: $9.26 - $26.70 Next Earning Date: 05-02-2024
Revenue: $219,788,000 Revenue Growth: 60.38%
Revenue Growth (this year): 10.1% Revenue Growth (next year): 8.46%

Share on Social Networks: